Archive: Innovative Research Tool Pinpoints Potential Therapies for Multiple Sclerosis
A team led by UCSF scientists has identified eight drugs that may stimulate nervous system repair in multiple sclerosis (MS).
Displaying 481 - 510 of 577
-
-
Archive: First Pediatric Autism Study Conducted Entirely Online
UCSF researchers have completed the first Internet-based clinical trial for children with autism, establishing it as a viable and cost effective method of conducting high-quality and rapid clinical trials in this population.
-
Archive: Running, Combined with Visual Experience, Restores Brain Function
In a new study by UC San Francisco scientists, running, when accompanied by visual stimuli, restored brain function to normal levels in mice that had been deprived of visual experience in early life.
-
Archive: Families With an Autistic Child Are a Third Less Likely to Have More Kids
Parents who have a child with autism spectrum disorder (ASD) are about one third less likely to have more children than families without an affected child, according to a study led by a UC San Francisco researcher.
-
Archive: Online Project Aims to Speed Up Cures for Brain Disorders
The Brain Health Registry – led by top researchers at UC San Francisco – is a new, groundbreaking, web-based project designed to speed up cures for Alzheimer’s, Parkinson’s and other brain disorders.
-
Archive: New York Times Conference Tackles Tomorrow's Health Challenges
The New York Times Health for Tomorrow conference, held at UCSF, featured experts from the University of California and across the country, addressing the changing landscape of health care.
-
Archive: Untangling Brain Circuits in Mental Illness
Funded through President Obama's Brain Initiative, a UCSF-led team is embarking on a $26 million project to develop a revolutionary and long-lasting treatment for depression, anxiety disorders, addiction and other neuropsychiatric disorders.
-
Archive: New Venture Aims to Understand and Heal Disrupted Brain Circuitry to Treat Mental Illnesses
Scientists and physicians at UCSF are leading a $26 million, multi-institutional research program to better understand and treat a range of common, debilitating psychiatric disorders.
-
Archive: Overlooked Cells Hold Keys to Brain Organization and Disease, UCSF Study Shows
Scientists studying brain diseases may need to look beyond nerve cells and start paying attention to the star-shaped cells known as “astrocytes,” because they play specialized roles in the development and maintenance of nerve circuits and may contribute to a wide range of disorders, according to a new study by UCSF researchers.
-
Archive: Private Partnerships for Public Benefit
Nobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.
-
Archive: UCSF Researchers Among Those Recognized by President Obama
Four UCSF-affiliated researchers are among 102 recipients of the Presidential Early Career Awards for Scientists and Engineers.
-
Archive: Groundbreaking Online Registry to Drive Brain Disease Research
A new online project led by researchers at UCSF promises to dramatically cut the time and cost of conducting clinical trials for brain diseases, while also helping scientists analyze and track the brain functions of thousands of volunteers over time.
-
Archive: Daiichi Sankyo and UCSF Announce Collaboration in Drug Discovery Research for Neurodegenerative Diseases
Daiichi Sankyo and UCSF have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.
-
Archive: Early Cardiac Risks Linked to Worse Cognitive Function in Middle Age
Young adults with such cardiac risk factors as high blood pressure and elevated glucose levels have significantly worse cognitive function in middle age, according to a new study by dementia researchers at UCSF.
-
Archive: A Beautiful Mind
Researchers are recording brain activity in visually stunning ways that could lead to targeted therapies for Alzheimer’s, autism and other diseases.
-
Archive: New High-Tech Lab Records the Brain and Body in Action
UCSF neuroscientist Adam Gazzaley, MD, PhD, is hoping to paint a fuller picture of what is happening in the minds and bodies of those suffering from brain disease with his new lab, Neuroscape, which bridges the worlds of neuroscience and high-tech.
-
Archive: Marijuana-Derived Epilepsy Drug in Clinical Trial for Children with Uncontrolled Seizures
A new study led by researchers from UCSF Benioff Children’s Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy.
-
Archive: UCSF Team Reveals How the Brain Recognizes Speech Sounds
UCSF researchers are reporting a detailed account of how speech sounds are identified by the human brain. The finding offers unprecedented insight into the basis of human language and may shed light on language disorders, including dyslexia.
-
Archive: UCSF, Quest Diagnostics Launch Collaboration to Advance Precision Medicine
UCSF and Quest Diagnostics, the world's leading provider of diagnostic information services, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine.
-
Archive: Molecular Sensor Detects Early Signs of Multiple Sclerosis, Gladstone Study Finds
Scientists at the UCSF-affiliated Gladstone Institutes have devised a new molecular sensor that can detect MS at its earliest stages, even before the onset of physical signs.
-
Archive: Scientists Pinpoint Cell Type and Brain Region Affected by Gene Mutations in Autism
A team led by UCSF scientists has identified the disruption of a single type of cell – in a particular brain region and at a particular time in brain development – as a significant factor in the emergence of autism.
-
Big Data, Tailored Care
Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
-
Archive: MEDIA ADVISORY: Opening of New “Center of Excellence” for Treatment of Dystonia and Parkinson’s Disease
UCSF, a world-renowned center for the treatment of movement disorders, is holding an event to celebrate the program’s recognition by the Bachmann-Strauss Foundation as one of three new Centers of Excellence in the field.
-
Archive: Anti-Aging Research Advances Featured in QB3 Symposium
Eleven leading scientists from the California Institute for Quantitative Biosciences (QB3) presented their latest aging research findings and anti-aging strategies at a daylong symposium called “The Science of Staying Younger Longer.”
-
Archive: Team Develops Targeted Therapies for Pain and Inflammation
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.
-
Archive: Potential Drug Discovered for Severe Form of Epilepsy
An antihistamine discovered in the 1950s to treat itching may also prevent seizures in an intractable form of childhood epilepsy, according to researchers at UC San Francisco who tested it in zebrafish bred to mimic the disease.
-
Archive: Global Team Identifies New Genes Behind Severe Childhood Epilepsy
An international study on epilepsy has uncovered 25 new mutations on nine key genes that could pave the way to develop precise therapies for a devastating form of the disorder during childhood.
-
Archive: Anemia Linked to Increased Risk of Dementia
Anemia, or low levels of red blood cells, may increase the risk of dementia, according to a new UCSF-led study that found people who were anemic had a nearly 41 percent higher risk of developing the condition than those who were not.
-
Archive: Scientists Identify Key Brain Circuits that Control Compulsive Drinking in Rats
A research team led by scientists from the Ernest Gallo Clinic and Research Center at UCSF has identified circuitry in the brain that drives compulsive drinking in rats, and likely plays a similar role in humans.
-
Archive: Failure to Destroy Toxic Protein, Not Buildup of Protein Itself, Contributes to Progression of Huntington’s Disease
Scientists at the UCSF-affiliated Gladstone Institutes have discovered that the progression of neurodegenerative disease is not due to the buildup of brain toxins itself, but rather in the individual neurons’ ability to dissolve them.